ZIMMER BIOMET HOLDINGS, INC. (ZBH) › Cash & EquivalentsZIMMER BIOMET HOLDINGS, INC. (ZBH) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2006: $265.70M2007: $463.90M2008: $212.60M2009: $691.70M2010: $668.90M2011: $768.30M2012: $884.30M2013: $1.08B2014: $1.08B2015: $1.46B2016: $634.10M2017: $524.40M2018: $542.80M2019: $617.90M2020: $802.10M2021: $378.10M2022: $375.70M2023: $415.80M2024: $525.50M2025: $591.90M$591.90M2006Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$591.90M+12.6%2024$525.50M+26.4%2023$415.80M+10.7%2022$375.70M-0.6%2021$378.10M-52.9%2020$802.10M+29.8%2019$617.90M+13.8%2018$542.80M+3.5%2017$524.40M-17.3%2016$634.10M-56.5%2015$1.46B+34.7%2014$1.08B+0.2%2013$1.08B+22.2%2012$884.30M+15.1%2011$768.30M+14.9%2010$668.90M-3.3%2009$691.70M+225.4%2008$212.60M-54.2%2007$463.90M+74.6%2006$265.70M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share